- Home
- SNTI vs LSF Comparison
SNTI vs LSF Comparison
Compare SNTI & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNTI | LSF |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.5M | 23.8M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SNTI | LSF |
|---|---|---|
| Price | $0.86 | $2.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $8.50 | $6.00 |
| AVG Volume (30 Days) | ★ 100.1K | 46.0K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.31 | 75.28 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $49,889,286.00 |
| Revenue This Year | $7,627.27 | $15.61 |
| Revenue Next Year | N/A | $15.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.23 |
| 52 Week Low | $0.77 | $1.96 |
| 52 Week High | $5.10 | $7.94 |
Technical Indicators
Market Signals| Indicator | SNTI | LSF |
|---|---|---|
| Relative Strength Index (RSI) | 44.15 | 51.69 |
| Support Level | $0.80 | $2.41 |
| Resistance Level | $1.02 | $2.76 |
| Average True Range (ATR) | 0.06 | 0.21 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 38.33 | 78.47 |
Price Performance
Historical ComparisonAbout SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.